Skip to main content
. 2018 Jun 28;16(3):3215–3222. doi: 10.3892/ol.2018.9049

Table IV.

PET/CT manifestations, T/B cell ratios and treatment responses of 18 treated patients with AA.

No. Sex Age, years Diagnosis PET/CT manifestation SUVmax T/B cell ratio Therapeutic regimen Efficacy
1 Male 24 CAA Hypometabolism complicated by focal hyperproliferation 6.10 5.62 CsA CR
2 Male 50 CAA Hypometabolism complicated by focal hyperproliferation 8.80 13.86 CsA PR
3 Female 59 CAA Diffuse hypometabolism 1.80 16.85 CsA PR
4 Female 60 CAA Hypometabolism complicated by focal hyperproliferation 2.90 2.22 CsA NC
5 Male 23 CAA Hypometabolism complicated by focal hyperproliferation 3.20 8.74 CsA PR
6 Female 54 CAA Hypometabolism complicated by focal hyperproliferation 2.20 7.61 CsA PR
7 Female 34 SAA Normal metabolism 2.00 3.02 ATG PR
8 Male 14 SAA Hypometabolism complicated by focal hyperproliferation 2.50 2.53 ATG PR
9 Male 27 SAA Hypometabolism complicated by focal hyperproliferation 2.70 5.62 ATG CR
10 Female 75 SAA Diffuse hypometabolism 1.10 3.07 CsA CR
11 Female 26 SAA Hypometabolism complicated by focal hyperproliferation 3.10 8.99 CsA NC
12 Male 36 SAA Hypometabolism complicated by focal hyperproliferation 5.00 5.86 CsA NC
13 Male 48 SAA Diffuse hypometabolism 1.50 5.28 CsA PR
14 Male 13 SAA Diffuse hypometabolism 1.3 10.51 Allo-BMT CR
15 Female 43 SAA Hypometabolism complicated by focal hyperproliferation 4.5 7.43 Compatriots CR
16 Male 43 SAA Hypometabolism complicated by focal hyperproliferation 2.8 3.66 Compatriots CR
17 Male 43 SAA Hypometabolism complicated by focal hyperproliferation 3.0 7.22 Compatriots CR
18 Male 37 SAA Hypometabolism complicated by focal hyperproliferation 3.0 16.75 Compatriots CR

CAA, chronic aplastic anemia; SAA, severe aplastic anemia; PET/CT, positron emission tomography/computed tomography; SUVmax, maximum standardized uptake values; T/B cell ratio, ratio between T lymphocytes and B lymphocytes; CsA, ciclosporin A; Allo-BMT, allogeneic bone marrow transplantation from a human leucocyte antigen-identical sibling donor; CR, complete remission; PR, partial remission; NC, no change.